John D. Pruitt

TL;DR: In this article, the authors proposed liquid dosage compositions of stable nanoparticulate active agents against crystal and particle size growth of the active agent. But their formulations were limited to osmotically active crystal growth inhibitors.

TL;DR: In this paper, the authors describe a class of nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least surface stabilizer, with an average particle size of less than about 2000 nm.

TL;DR: In this article, the authors proposed a method for the synthesis of nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.

TL;DR: In this paper, the present invention relates to liquid dosage forms of nanoparticulate active agents having very low viscosities, and it relates to the use of liquid dosage form of nanopARTiculate agents.